GLP-1 medications do reduce appetite, but they also slow stomach emptying, improve fullness signaling, and help regulate blood sugar by affecting insulin and glucagon pathways
Medium-chain triglycerides (MCTs) consisting of decanoate (C10:0) can improve glucose tolerance and inhibit HFD-induced obesity in mice by stimulating GLP-1 secretion through GPR84 [148]
Product Benefits: ADVANCED GLP-1 ACTIVATION FORMULA: Each capsule is packed with a proprietary GLP-1 activation blend featuring 100mg Berberine Phytosome, 30mg Fenugreek Extract, and 1mg Chromium, carefully formulated to support/activate GLP-1
You can expect to receive your medication anywhere between 4 and 7 business days
has acted as a speaker for Novo Nordisk and has received grants from Novo Nordisk, Novo Nordisk UK Research Foundation, Academy of Medical Sciences/ Diabetes UK and Health Education East Midlands